Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial †
Titel:
Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial †
Auteur:
Zdenkowski, N. Forbes, J.F. Boyle, F.M. Kannourakis, G. Gill, P.G. Bayliss, E. Saunders, C. Della-Fiorentina, S. Kling, N. Campbell, I. Mann, G.B. Coates, A.S. Gebski, V. Davies, L. Thornton, R. Reaby, L. Cuzick, J. Green, M.